Skip to main content
. 2022 Mar 21;182(5):482–491. doi: 10.1001/jamainternmed.2022.0217

Table 2. Unadjusted and Adjusted Rate of Complete Medication Abortion by Characteristics of the Sample.

Characteristic Unadjusted complete case effectiveness rate, % (95% CI) P value Adjusted imputed effectiveness rate, % (95% CI)a P value
No. 2397 NA 3779 NA
Overall 94.5 (92.9-96.1) NA 94.8 (93.6-95.9) NA
Age at mifepristone provision, y
<24 96.4 (94.8-98.0) [Reference] 96.6 (95.3-98.0) [Reference]
25-34 94.1 (92.2-96.8) .01 94.3 (92.8-95.9) .02
≥35 92.8 (90.0-95.6) .004 92.6 (89.9-95.3) .002
Race and ethnicity
Black 93.8 (91.2-96.5) .88 93.9 (91.5-96.2) .43
Latinx/Hispanic 96.4 (94.1-98.7) .13 96.3 (94.1-98.6) .31
White 94.0 (92.0-96.1) [Reference] 94.9 (93.4-96.4) [Reference]
Multiracial or otherb 93.8 (90.1-97.5) .90 93.7 (90.1-97.3) .53
Residence
Urban 94.0 (91.6-96.5) [Reference] 94.2 (91.9-96.5) [Reference]
Rural 94.7 (93.0-96.4) .61 94.9 (93.6-96.2) .57
Previous medication abortion
None 94.6 (92.8-96.3) [Reference] 94.7 (93.4-95.9) [Reference]
Any 95.1 (92.6-97.5) .69 95.1 (92.9-97.3) .70
Participated in the TelAbortion study
No 94.1 (92.1-96.0) [Reference] 94.4 (93.2-95.8) [Reference]
Yes 96.0 (93.9-98.2) .14 96.3 (94.3-98.2) .17
Method of mifepristone provision
In person 94.9 (93.1-96.7) [Reference] 95.4 (94.1-96.7) [Reference]
Mailed 94.0 (91.8-96.3) .54 93.3 (90.7-95.9) .14
Pregnancy duration, d
<43 95.2 (93.4-97.1) [Reference] 95.5 (94.1-97.0) [Reference]
43-56 95.2 (93.4-97.0) .97 95.5 (94.1-96.9) >.99
≥57 90.9 (87.1-94.6) .004 90.9 (87.6-94.2) .003
a

Multivariable estimates are adjusted for all other covariates in the table. Both models are mixed-effects models estimated with clinic as a random intercept.

b

The “other” category included Alaska Native, American Indian, Asian, Asian Indian, Filipino, Guyanian, Guamanian/Chamorro, Japanese, Middle Eastern, Native American, Native Hawaiian, Pacific Islander, and Turkish.